- A test developed by the Institute for Animal Science and Health, for the early detection of BSE and CJD, is under assessment by the UK Veterinary Laboratories Agency. Using scrapie as a model, the researchers reported in Nature (June 13) that they have developed antibodies which bind to the abnormal prion responsible for the diseases. This test was used on a tonsil biopsy of a 10-month-old sheep, detecting the disease in less than half the normal incubation time. Present diagnosis relies on post-mortem studies of brain tissue.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze